Home Featured Page 183

Featured

Latest

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

Religious Practice Under Oregon Measure 109

Silo Pharma Extends Exclusive Option Agreement for Homing Peptides

Looking Ahead to a Psychedelic 2022

Entheon Biomedical Announces the Approval of DMT Clinical Trial

MINDCURE Hires Dr. Clare Purvis from Headspace to the position of...

Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity...

Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying...

Mydecine Welcomes Dr. Victoria Hale as Newest Independent Board Member

Small Pharma Reports Fiscal Third Quarter 2021 Highlights

IntelGenx Receives Third Loan Tranche from atai

1...182183184...301 Page 183 of 301

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

Compass Pathways Accelerates Psilocybin Launch Timeline by 9-12 Months

CLOSING RECEPTION Travis Gillan’s Revelator

Religious Practice Under Oregon Measure 109

Silo Pharma Extends Exclusive Option Agreement for Homing Peptides

Looking Ahead to a Psychedelic 2022

Entheon Biomedical Announces the Approval of DMT Clinical Trial

MINDCURE Hires Dr. Clare Purvis from Headspace to the position of...

Psyched Wellness Announces Additional Positive Results from the 14-day Oral Toxicity...

Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying...

Mydecine Welcomes Dr. Victoria Hale as Newest Independent Board Member

Small Pharma Reports Fiscal Third Quarter 2021 Highlights

IntelGenx Receives Third Loan Tranche from atai

EDITOR PICKS

Review: Colorado Psychedelic Cup 2025

Dr Ros Watts – Building Communities and Connection

The Psychedelic News Feed: October 27 – November 02, 2025

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY